Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling

References 50

1. 1.
   Differential expression analysis for sequence count data · 2010

   No notice
2. 2.

   Arensman MD, Yang XS, Leahy DM, Toral-Barza L, Mileski M, Rosfjord EC, Wang F, Deng S, Myers JS, Abraham RT, et al. Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity. Proc Natl Acad Sci USA. 2019;116:9533-9542.

   Not in our library10.1073/pnas.1814932116

3. 3.

   Austin CJ, Mailu BM, Maghzal GJ, Sanchez-Perez A, Rahlfs S, Zocher K, Yuasa HJ, Arthur JW, Becker K, Stocker R, et al. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2. Amino Acids. 2010;39:565-578.

   Not in our library10.1007/s00726-010-0475-9

4. 4.

   Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013;339:1323-1328.

   Not in our library10.1126/science.1228792

5. 5.

   Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature. 2014;511:184-190.

   Not in our library10.1038/nature13323

6. 6.

   Byrne GI, Lehmann LK, Kirschbaum JG, Borden EC, Lee CM, Brown RR. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J Interferon Res. 1986;6:389-396.

   Not in our library10.1089/jir.1986.6.389

7. 7.

   Costa-Mattioli M, Walter P. The integrated stress response: From mechanism to disease. Science. 2020;368:eaat5314.

   Not in our library10.1126/science.aat5314

8. 8.

   Davidson AJ, Wood W. Igniting the spread of ferroptotic cell death. Nat Cell Biol. 2020;22:1027-1029.

   Not in our library10.1038/s41556-020-0570-4

9. 9.

   Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060-1072.

   Not in our library10.1016/j.cell.2012.03.042

10. 10.
    Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis · 2014

    No notice
11. 11.

    Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.

    Not in our library10.1093/bioinformatics/bts635

12. 12.

    Eynde BJVd, Baren Nv, Baurain J-F. Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma? Annu Rev Cancer Biol. 2020;4:241-256.

    Not in our library

13. 13.

    Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7-14.

    Not in our library10.1016/j.coi.2020.12.001

14. 14.
    Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment · 2019

    No notice
15. 15.

    Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247-250.

    Not in our library10.1038/nature24297

16. 16.

    Kelly B, Carrizo GE, Edwards-Hicks J, Sanin DE, Stanczak MA, Priesnitz C, Flachsmann LJ, Curtis JD, Mittler G, Musa Y, et al. Sulfur sequestration promotes multicellularity during nutrient limitation. Nature. 2021;591:471-476.

    Not in our library10.1038/s41586-021-03270-3

17. 17.

    Labadie BW, Bao R, Luke JJ. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis. Clin Cancer Res. 2019;25:1462-1471.

    Not in our library10.1158/1078-0432.ccr-18-2882

18. 18.

    Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;41:e108.

    Not in our library10.1093/nar/gkt214

19. 19.

    Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923-930.

    Not in our library10.1093/bioinformatics/btt656

20. 20.

    Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz PS, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA. 2014;111:16836-16841.

    Not in our library10.1073/pnas.1415518111

21. 21.

    Liu Y, Liang X, Dong W, Fang Y, Lv J, Zhang T, Fiskesund R, Xie J, Liu J, Yin X, et al. Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation. Cancer Cell. 2018;33:480-494.

    Not in our library10.1016/j.ccell.2018.02.005

22. 22.

    Long GV, Dummer R, Hamid O, Gajewski TF, Caglevic C, Dalle S, Arance A, Carlino MS, Grob JJ, Kim TM, et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncol. 2019;20:1083-1097.

    Not in our library10.1016/s1470-2045(19)30274-8

23. 23.

    Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, Verrey F. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature. 1998;395:288-291.

    Not in our library10.1038/26246

24. 24.
    IDO Expression in Cancer: Different Compartment, Different Functionality? · 2020

    No notice
25. 25.

    Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today. 1999;20:469-473.

    Not in our library10.1016/s0167-5699(99)01520-0

26. 26.

    Michlits G, Jude J, Hinterndorfer M, de Almeida M, Vainorius G, Hubmann M, Neumann T, Schleiffer A, Burkard TR, Fellner M, et al. Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles. Nat Methods. 2020;17:708-716.

    Not in our library10.1038/s41592-020-0850-8

27. 27.

    Minhas PS, Liu L, Moon PK, Joshi AU, Dove C, Mhatre S, Contrepois K, Wang Q, Lee BA, Coronado M, et al. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nat Immunol. 2019;20:50-63.

    Not in our library10.1038/s41590-018-0255-3

28. 28.

    Murray PJ. Amino acid auxotrophy as a system of immunological control nodes. Nat Immunol. 2016;17:132-139.

    Not in our library10.1038/ni.3323

29. 29.

    Nagane M, Kanai E, Shibata Y, Shimizu T, Yoshioka C, Maruo T, Yamashita T. Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma. PLoS One. 2018;13:e0195151.

    Not in our library10.1371/journal.pone.0195151

30. 30.

    Nakamura A, Nambu T, Ebara S, Hasegawa Y, Toyoshima K, Tsuchiya Y, Tomita D, Fujimoto J, Kurasawa O, Takahara C, et al. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response. Proc Natl Acad Sci USA. 2018;115:E7776-E7785.

    Not in our library10.1073/pnas.1805523115

31. 31.

    Newman AC, Falcone M, Huerta Uribe A, Zhang T, Athineos D, Pietzke M, Vazquez A, Blyth K, Maddocks ODK. Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells. Mol Cell. 2021;81:2290-2302.

    Not in our library10.1016/j.molcel.2021.03.019

32. 32.

    Okunushi K, Furihata T, Morio H, Muto Y, Higuchi K, Kaneko M, Otsuka Y, Ohno Y, Watanabe Y, Reien Y, et al. JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function. J Pharmacol Sci. 2020;144:16-22.

    Not in our library10.1016/j.jphs.2020.06.006

33. 33.

    Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011;478:197-203.

    Not in our library10.1038/nature10491

34. 34.
    Molecular basis for redox control by the human cystine/glutamate antiporter system xc− · 2021

    No notice
35. 35.

    Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA. 1984;81:908-912.

    Not in our library10.1073/pnas.81.3.908

36. 36.

    Pfefferkorn ER, Eckel M, Rebhun S. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol Biochem Parasitol. 1986;20:215-224.

    Not in our library10.1016/0166-6851(86)90101-5

37. 37.

    Poltorack CD, Dixon SJ. Understanding the role of cysteine in ferroptosis: progress & paradoxes. FEBS J. 2021;289:374-385.

    Not in our library10.1111/febs.15842

38. 38.

    Procaccini C, Garavelli S, Carbone F, Di Silvestre D, La Rocca C, Greco D, Colamatteo A, Lepore MT, Russo C, De Rosa G, et al. Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential. Immunity. 2021;54:1543-1560.

    Not in our library10.1016/j.immuni.2021.04.014

39. 39.

    Schmidt JV, Bradfield CA. Ah receptor signaling pathways. Annu Rev Cell Dev Biol. 1996;12:55-89.

    Not in our library10.1146/annurev.cellbio.12.1.55

40. 40.
    Single cell analysis of kynurenine and System L amino acid transport in T cells · 2018

    No notice

Cited by papers we hold 4

• Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies · 2024
  No notice
• To metabolomics and beyond: a technological portfolio to investigate cancer metabolism · 2023
  No notice
• Immune regulation through tryptophan metabolism · 2023
  No notice
• Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth · 2023
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.